↓ Skip to main content

Belimumab or anifrolumab for systemic lupus erythematosus? A risk-benefit assessment

Overview of attention for article published in Frontiers in immunology, August 2022
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
11 Dimensions

Readers on

mendeley
48 Mendeley